A Strategic Translational Research System for Drug Discovery in Tottori University

被引:0
|
作者
Endo, Yusuke [1 ]
Yoshida, Tsutomu [1 ]
Washijima, Ichiro [1 ]
Ueki, Masaru [1 ]
Kikuchi, Noriyoshi [2 ]
Takenaka, Atsushi [1 ]
Kawata, Yasushi [2 ]
机构
[1] Tottori Univ, Org Res Inst & Promot, Yonago 6838503, Japan
[2] Tottori Univ, Org Res Inst & Promot, Tottori 6808550, Japan
关键词
Key words drug discovery; open innovation; translational research; INNOVATION; DECADE;
D O I
10.33160/yam.2023.11.001
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The probability of successful drug discovery is declin-ing, and research and development costs are increasing. To solve these problems, pharmaceutical companies tend to in-license seeds from venture companies and academia. Therefore, academia's role in drug discovery is extremely important. Tottori University started a "Next-Generation Research Support Project (Strategic Research Support Project)" in 2020, developing a trans-lational research system to promote drug discovery. In this project, we established a research and development infrastructure, such as seed registration, construction of drug research and development support, and research fund allocation. The registered seed were converted into project, and the project implemented this research and development system, and evaluated and verified its results. Twenty-two seeds were converted into projects and portfolios were constructed. Research funds were allocated to eight prioritized projects. Each project raised the research and development stages. From the overall portfolio, one project with the Japan Agency for Medical Research and Development (AMED) Drug Discovery Booster Project, and three projects with Seeds A of the AMED Translational Research Strategic Promotion Program were adopted. Additionally, a new low-molecular weight chaperone drug against GM1-gangliosidosis was out-licensed to an overseas pharmaceutical company. The strength of this system was the strategic allocation of research funds and the accompanying support that leveraged internal and external resources with the PM and researchers at its core. This system achieved certain results in promot-ing drug discovery; however, resource optimization of specialized personnel needs to be strengthened in the future. In this report, we summarized the efforts of translational research in Japan and around the world. In addition, the translational research efforts of Japanese academia and Tottori University were compared and the current status was summarized.
引用
收藏
页码:394 / 403
页数:10
相关论文
共 50 条
  • [1] Translational research in central nervous system drug discovery
    Hurko O.
    Ryan J.L.
    [J]. NeuroRX, 2005, 2 (4): : 671 - 682
  • [2] Translational research: the changing landscape of drug discovery
    Fishburn, C. Simone
    [J]. DRUG DISCOVERY TODAY, 2013, 18 (9-10) : 487 - 494
  • [3] Translational research: Drug discovery from the inside
    Derek Lowe
    [J]. Nature Chemical Biology, 2015, 11 (4) : 239 - 239
  • [4] Applications of Flow Cytometry in Drug Discovery and Translational Research
    Ullas, Sumana
    Sinclair, Charles
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [5] canSAR: update to the cancer translational research and drug discovery knowledgebase
    di Micco, Patrizio
    Antolin, Albert A.
    Mitsopoulos, Costas
    Villasclaras-Fernandez, Eloy
    Sanfelice, Domenico
    Dolciami, Daniela
    Ramagiri, Pradeep
    Mica, Ioan L.
    Tym, Joseph E.
    Gingrich, Philip W.
    Hu, Huabin
    Workman, Paul
    Al-Lazikani, Bissan
    [J]. NUCLEIC ACIDS RESEARCH, 2023, 51 (D1) : D1212 - D1219
  • [6] canSAR: update to the cancer translational research and drug discovery knowledgebase
    Coker, Elizabeth A.
    Mitsopoulos, Costas
    Tym, Joesph E.
    Komianou, Angeliki
    Kannas, Christos
    Di Micco, Patrizio
    Fernandez, Eloy Villasclaras
    Ozer, Bugra
    Antolin, Albert A.
    Workman, Paul
    Al-Lazikani, Bissan
    [J]. NUCLEIC ACIDS RESEARCH, 2019, 47 (D1) : D917 - D922
  • [7] canSAR: update to the cancer translational research and drug discovery knowledgebase
    Mitsopoulos, Costas
    Di Micco, Patrizio
    Fernandez, Eloy Villasclaras
    Dolciami, Daniela
    Holt, Esty
    Mica, Ioan L.
    Coker, Elizabeth A.
    Tym, Joseph E.
    Campbell, James
    Che, Ka Hing
    Ozer, Bugra
    Kannas, Christos
    Antolin, Albert A.
    Workman, Paul
    Al-Lazikani, Bissan
    [J]. NUCLEIC ACIDS RESEARCH, 2021, 49 (D1) : D1074 - D1082
  • [8] Translational Research and Drug Discovery for Neurodegeneration: Challenges for Latin America
    Rao, K. S. Jagannatha
    Britton, Gabrielle B.
    Arrieta, Luisa Lilia Rocha
    Garcia-Cairasco, Norberto
    Lazarowski, Alberto
    Palacios, Adrian
    Espuny, Antoni Camins
    Maccioni, Ricardo B.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2021, 82 : S1 - S4
  • [9] Translational research on drug development and biomarker discovery for hepatocellular carcinoma
    Chew, Valerie
    Chuang, Chien-Huai
    Hsu, Chiun
    [J]. JOURNAL OF BIOMEDICAL SCIENCE, 2024, 31 (01)
  • [10] Translational research on drug development and biomarker discovery for hepatocellular carcinoma
    Valerie Chew
    Chien-Huai Chuang
    Chiun Hsu
    [J]. Journal of Biomedical Science, 31